Notably, T-ALL patients with high NFE2L2 levels showed significant enrichment of genetic signatures related to the metabolism of xenobiotics and drug resistance (Figure 4B and Figure S4B). Here, NFE2L2 is linked to acute lymphoblastic leukemia.